E3S Web of Conferences
Volume 1, 2013Proceedings of the 16th International Conference on Heavy Metals in the Environment
|Number of page(s)||2|
|Section||Heavy Metals and Human Health|
|Published online||23 April 2013|
Arsenic and cardiovascular diseases
Institute of Clinical Physiology, National Research Council, Pisa, Italy
A growing body of epidemiologic, experimental and clinical evidence shows that arsenic may exert relevant cardiovascular effects with early damage such as endothelial dysfunction. Early biomarkers of cardiovascular damage together with markers of exposure, genetic and epigenetic effects, DNA damage, apoptosis, oxidative stress remain unexplored and a study is ongoing in Italy.
Key words: cardiovascular diseases / arsenic / biomonitoring / early markers of cardiovascular effects
© Owned by the authors, published by EDP Sciences, 2013
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 2.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.